Live from the NIH registry
Studies recruiting near Cape Coral right now
Top 25 of 242 recruiting studies, sorted by proximity — each links to its official registry page
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Fort Myers, Florida (9.7 mi)
· Sponsor: AstraZeneca
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Medsol Clinical Research Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Florida Cancer Specialists & Research Institute - South — Fort Myers, Florida (9.7 mi)
· Sponsor: Revolution Medicines, Inc.
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
Advanced Solid Tumors
Phase 2
Interventional 14 participants sought
Florida Cancer Specialists - Fort Myers — Fort Myers, Florida (9.7 mi)
· Sponsor: Amgen
A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Wet Age Related Macular Degeneration
Phase 2
Interventional 66 participants sought
Advanced Retina Institute — Bonita Springs, Florida (25.0 mi)
· Sponsor: NexThera Co., Ltd.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Children's Oncology Group
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Florida Cancer Specialists - South ( Site 7004) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Fort Myers, FL Investigative Site 10076 — Fort Myers, Florida (9.7 mi)
· Sponsor: Colorado Prevention Center
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1165 — Fort Myers, Florida (9.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
AMR Fort Myers (The Clinical Study Center) — Fort Myers, Florida (9.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (9.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Florida Cancer Specialists - South ( Site 7002) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
HealthPark Medical Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Medtronic Cardiovascular
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1016 — Port Charlotte, Florida (23.7 mi)
· Sponsor: Immunovant Sciences GmbH
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Fort Myers, Florida (9.7 mi)
· Sponsor: 89bio, Inc.
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Florida Cancer Specialists South — Fort Myers, Florida (9.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Peace River Cardiovascular Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: Boehringer Ingelheim
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Innovative Research Institute — Port Charlotte, Florida (23.7 mi)
· Sponsor: Sparrow Pharmaceuticals
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Schizophrenia, Bipolar Disorder
Phase 3
Interventional 300 participants sought
Royal Palm Clinical Research — Fort Myers, Florida (9.7 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (9.7 mi)
· Sponsor: Merus B.V.
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
544 — Fort Myers, Florida (9.7 mi)
· Sponsor: Corcept Therapeutics
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Alliance for Multispecialty Research - Fort Myers — Fort Myers, Florida (9.7 mi)
· Sponsor: Amgen
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
CIN 2/3, HPV Infection
Phase 2
Interventional 78 participants sought
Florida Gynecologic Oncology — Fort Myers, Florida (9.7 mi)
· Sponsor: Frantz Viral Therapeutics, LLC
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Phase 3
Interventional 600 participants sought
Florida Cancer Specialists & Research Institute — Fort Myers, Florida (9.7 mi)
· Sponsor: Janssen Research & Development, LLC